Digital healthcare company Ro offers prescriptions for hair loss, menopause, and sexual health.
Now it's becoming the first online pharmacy to offer FDA-approved allergy treatments. The segment includes up to 50 million people in the U.S. who suffer from the chronic condition.
"If you look at a condition like allergies, it's perfect for our platform," Dr. Melynda Barnes, vice president of medical affairs, told Cheddar. "We have the capability of doing everything from diagnosis to delivery of treatment."
Ro is the parent company behind digital health clinics Roman (for men) and Rory (for women) as well as a service for dealing with nicotine addiction called Zero.
Its platforms will offer allergy medicine to patients, which furthers the startup's goal of serving as a one-stop-shop for basic health needs.
"Our goal at Ro is to be a patient's first call, and for us, that means moving toward a primary care practice," Barnes said.
Though many allergy treatments are available over the counter, research shows that 80 percent of people choose the incorrect medication on their own. Using telehealth options for quick access to a certified physician, Ro hopes to take out the guesswork for patients.
"I don't think we'll ever replace in-person care," Barnes said. "In fact, at Ro, our goal is to be a complement to our in-person colleagues."
But that hasn't stopped Ro from expanding into other aspects of personal healthcare, including spreading knowledge to patients online.
The company recently launched Health Guide, a medical handbook that is 30 percent written by doctors and 100 reviewed by them. Ro is promoting the service as a competitor to WebMD.
"Right now, we know that physicians feel like they can spend more time with really sick patients if they can take care of healthier patients through an alternative health care model like telemedicine," Barnes said.
It's a tough time for the job market. Amid wider economic uncertainty, some analysts have said that businesses are at a “no-hire, no fire” standstill. At the same time, some sizeable layoffs have continued to pile up — raising worker anxieties across sectors. Some companies have pointed to rising operational costs due to U.S.'s new tariffs, while others have redirected money to artificial intelligence investments. Workers in the public sector have also been hit hard. Federal jobs were cut by the thousands earlier this year. And many workers are now going without pay as the U.S. government shutdown has now dragged on for more than a month.
Nvidia smashes earnings with record-breaking revenue and soaring Blackwell demand as shares slip this morning, Barron’s senior writer Adam Levine unpacks it all
Jeff Wagoner, CEO of Outrigger Hospitality Group, discusses the company’s coral preservation initiatives and sustainable practices at their hotels and resorts.
Dena Jalbert, Head of M&A at Align Advisory, discusses the state of mergers and acquisitions in 2025 and beyond, highlighting key trends and opportunities.
Kim Perell, author and entrepreneur, shares actionable tips and tricks to help current and aspiring entrepreneurs kick off 2026 with confidence and momentum.
Computer chipmaker Nvidia is poised to release a quarterly earnings report that is expected to either deepen a recent downturn in the stock market or prompt an ebullient sigh of relief among investors increasingly worried the world’s most valuable company is perched upon an artificial intelligence bubble about to burst.
Emera CEO Scott Balfour discusses soaring energy demand, AI-driven grid challenges, clean-power investments, and how the company is building a resilient future.
JB Mackenzie discusses Robinhood’s new entertainment prediction markets, letting users engage with pop culture, award shows, and more through low-stakes bets.
